Central limit theorems for iterated random Lipschitz mappings

Let M be a noncompact metric space in which every closed ball is compact, and let G be a semigroup of Lipschitz mappings of M. Denote by (Y_n)_{n\geq1} a sequence of independent G-valued, identically distributed random variables (r.v.'s), and by Z an M-valued r.v. which is independent of the r.v. Y_n, n\geq1. We consider the Markov chain (Z_n)_{n\geq0} with state space M which is defined recursively by Z_0=Z and Z_{n+1}=Y_{n+1}Z_n for n\geq0. Let \xi be a real-valued function on G\times M. The aim of this paper is to prove central limit theorems for the sequence of r.v.'s (\xi(Y_n,Z_{n-1}))_{n\geq1}. The main hypothesis is a condition of contraction in the mean for the action on M of the mappings Y_n; we use a spectral method based on a quasi-compactness property of the transition probability of the chain mentioned above, and on a special perturbation theorem.Comment: Published by the Institute of Mathematical Statistics (http://www.imstat.org) in the Annals of Probability (http://www.imstat.org/aop/) at http://dx.doi.org/10.1214/00911790400000046

Dietary factors and low-grade inflammation in relation to overweight and obesity

Low-grade inflammation is a characteristic of the obese state, and adipose tissue releases many inflammatory mediators. The source of these mediators within adipose tissue is not clear, but infiltrating macrophages seem to be especially important, although adipocytes themselves play a role. Obese people have higher circulating concentrations of many inflammatory markers than lean people do, and these are believed to play a role in causing insulin resistance and other metabolic disturbances. Blood concentrations of inflammatory markers are lowered following weight loss. In the hours following the consumption of a meal, there is an elevation in the concentrations of inflammatory mediators in the bloodstream, which is exaggerated in obese subjects and in type 2 diabetics. Both high-glucose and high-fat meals may induce postprandial inflammation, and this is exaggerated by a high meal content of advanced glycation end products (AGE) and partly ablated by inclusion of certain antioxidants or antioxidant-containing foods within the meal. Healthy eating patterns are associated with lower circulating concentrations of inflammatory markers. Among the components of a healthy diet, whole grains, vegetables and fruits, and fish are all associated with lower inflammation. AGE are associated with enhanced oxidative stress and inflammation. SFA and trans-MUFA are pro-inflammatory, while PUFA, especially long-chain n-3 PUFA, are anti-inflammatory. Hyperglycaemia induces both postprandial and chronic low-grade inflammation. Vitamin C, vitamin E and carotenoids decrease the circulating concentrations of inflammatory markers. Potential mechanisms are described and research gaps, which limit our understanding of the interaction between diet and postprandial and chronic low-grade inflammation, are identifie

Quantitative nanohistology of aging dermal collagen

The skin is the largest organ in the body and is essential for protecting us from environmental stressors such as UV radiation, pollution, and pathogens. As we age, our skin undergoes complex changes that can affect its function, appearance, and health. These changes result from intrinsic (chronological) and extrinsic (environmental) factors that can cause damage to the skin’s cells and extracellular matrix. As higher-resolution microscopical techniques, such as Atomic Force Microscopy (AFM), are being deployed to support histology, it is possible to explore the biophysical properties of the dermal scaffold’s constituents, such as the collagen network. In this study, we demonstrate the use of our AFM-based quantitative nanohistology, performed directly on unfixed cryosections of 30 donors (female, Caucasian), to differentiate between dermal collagen from different age groups and anatomical sites. The initial 420 (10 × 10 μm2) Atomic Force Microscopy images were segmented into 42,000 (1 × 1 μm2) images before being classified according to four pre-defined empirical collagen structural biomarkers to quantify the structural heterogeneity of the dermal collagen. These markers include interfibrillar gap formation, undefined collagen structure, and registered or unregistered dense collagen fibrillar network with evident D-banding. The structural analysis was also complemented by extensive nanoindentation (∼1,000 curves) performed on individual fibrils from each section, yielding 30,000 indentation curves for this study. Principal Component Analysis was used to reduce the complexity of high-dimensional datasets. The % prevalence of the empirical collagen structural biomarkers between the papillary and reticular dermis for each section proves determinant in differentiating between the donors as a function of their age or the anatomical site (cheek or breast). A case of abnormal biological aging validated our markers and nanohistology approach. This case also highlighted the difference between chronological and biological aging regarding dermal collagen phenotyping. However, quantifying the impact of chronic and pathological conditions on the structure and function of collagen at the sub-micron level remains challenging and lengthy. By employing tools such as the Atomic Force Microscope as presented here, it is possible to start evaluating the complexity of the dermal matrix at the nanoscale and start identifying relevant collagen morphology which could be used toward histopathology standards

Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data

Background: Plasmodium falciparum malaria is associated with anaemia-related morbidity, attributable to host, parasite and drug factors. We quantified the haematological response following treatment of uncomplicated P. falciparum malaria to identify the factors associated with malarial anaemia. Methods: Individual patient data from eligible antimalarial efficacy studies of uncomplicated P. falciparum malaria, available through the WorldWide Antimalarial Resistance Network data repository prior to August 2015, were pooled using standardised methodology. The haematological response over time was quantified using a multivariable linear mixed effects model with nonlinear terms for time, and the model was then used to estimate the mean haemoglobin at day of nadir and day 7. Multivariable logistic regression quantified risk factors for moderately severe anaemia (haemoglobin < 7 g/dL) at day 0, day 3 and day 7 as well as a fractional fall ≥ 25% at day 3 and day 7. Results: A total of 70,226 patients, recruited into 200 studies between 1991 and 2013, were included in the analysis: 50,859 (72.4%) enrolled in Africa, 18,451 (26.3%) in Asia and 916 (1.3%) in South America. The median haemoglobin concentration at presentation was 9.9 g/dL (range 5.0–19.7 g/dL) in Africa, 11.6 g/dL (range 5.0–20.0 g/dL) in Asia and 12.3 g/dL (range 6.9–17.9 g/dL) in South America. Moderately severe anaemia (Hb < 7g/dl) was present in 8.4% (4284/50,859) of patients from Africa, 3.3% (606/18,451) from Asia and 0.1% (1/916) from South America. The nadir haemoglobin occurred on day 2 post treatment with a mean fall from baseline of 0.57 g/dL in Africa and 1.13 g/dL in Asia. Independent risk factors for moderately severe anaemia on day 7, in both Africa and Asia, included moderately severe anaemia at baseline (adjusted odds ratio (AOR) = 16.10 and AOR = 23.00, respectively), young age (age < 1 compared to ≥ 12 years AOR = 12.81 and AOR = 6.79, respectively), high parasitaemia (AOR = 1.78 and AOR = 1.58, respectively) and delayed parasite clearance (AOR = 2.44 and AOR = 2.59, respectively). In Asia, patients treated with an artemisinin-based regimen were at significantly greater risk of moderately severe anaemia on day 7 compared to those treated with a non-artemisinin-based regimen (AOR = 2.06 [95%CI 1.39–3.05], p < 0.001). Conclusions: In patients with uncomplicated P. falciparum malaria, the nadir haemoglobin occurs 2 days after starting treatment. Although artemisinin-based treatments increase the rate of parasite clearance, in Asia they are associated with a greater risk of anaemia during recovery

Research and Design of a Routing Protocol in Large-Scale Wireless Sensor Networks

无线传感器网络，作为全球未来十大技术之一，集成了传感器技术、嵌入式计算技术、分布式信息处理和自组织网技术，可实时感知、采集、处理、传输网络分布区域内的各种信息数据，在军事国防、生物医疗、环境监测、抢险救灾、防恐反恐、危险区域远程控制等领域具有十分广阔的应用前景。 本文研究分析了无线传感器网络的已有路由协议，并针对大规模的无线传感器网络设计了一种树状路由协议，它根据节点地址信息来形成路由，从而简化了复杂繁冗的路由表查找和维护，节省了不必要的开销，提高了路由效率，实现了快速有效的数据传输。 为支持此路由协议本文提出了一种自适应动态地址分配算——ADAR（AdaptiveDynamicAddre...As one of the ten high technologies in the future, wireless sensor network, which is the integration of micro-sensors, embedded computing, modern network and Ad Hoc technologies, can apperceive, collect, process and transmit various information data within the region. It can be used in military defense, biomedical, environmental monitoring, disaster relief, counter-terrorism, remote control of haz...学位：工学硕士院系专业：信息科学与技术学院通信工程系_通信与信息系统学号：2332007115216

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

CONTRIBUTION A L'ETUDE DE L'EVOLUTION DES GENES CODANT LA SOMATOSTATINE CHEZ LES VERTEBRES (MISE EN EVIDENCE CHEZ LES AMPHIBIENS ET LES DIPNEUSTES D'UN NOUVEAU VARIANT DE SOMATOSTATINE MUNI D'UN RESIDU PROLINE EN POSITION DEUX)

LA SOMATOSTATINE EST UN PEPTIDE DE 14 ACIDES AMINES (SS-14) QUI, EN TANT QUE NEUROMEDIATEUR OU NEUROHORMONE EXERCE DE MULTIPLES EFFETS, AUSSI BIEN DANS LE CERVEAU QUE DANS LES ORGANES PERIPHERIQUES. INITIALEMENT ISOLEE CHEZ LES MAMMIFERES, LA SS-14 A ENSUITE ETE RETROUVEE, SANS MODIFICATION DE SEQUENCE, DANS TOUS LES GROUPES DE VERTEBRES. DIVERS VARIANTS DE SOMATOSTATINE, ISSUS DE GENES DISTINCTS, ONT ETE PAR AILLEURS MIS EN EVIDENCE CHEZ PLUSIEURS ESPECES DE POISSONS. TOUTEFOIS, CHEZ LES TETRAPODES, IL ETAIT GENERALEMENT ADMIS QU'IL N'EXISTAIT QU'UN SEUL GENE DE SOMATOSTATINE. A L'OCCASION DU PRESENT TRAVAIL, NOUS REMETTONS EN CAUSE CETTE CONCEPTION EN MONTRANT L'EXISTENCE CHEZ LA GRENOUILLE RANA RIDIBUNDA DE DEUX GENES DISTINCTS DE SOMATOSTATINE. LE PREMIER CODE LA SS-14 CLASSIQUE (SS1), TANDIS QUE LE SECOND CODE LE VARIANT PRO 2, MET 1 3SS-14 (SS2). PAR AILLEURS, NOUS METTONS EN EVIDENCE, CHEZ LE DIPNEUSTE PROTOPTERUS ANNECTENS, L'EQUIVALENT DU GENE SS2, QUI CODE POUR UN NOUVEAU VARIANT DE SEQUENCE PRO 2SS-14. LE CARACTERE ORTHOLOGUE DES SS2 DE GRENOUILLE ET DE DIPNEUSTE S'APPUIE SUR LES OBSERVATIONS SUIVANTES : I) LA PRESENCE DANS LA SEQUENCE DES DEUX PEPTIDES D'UN RESIDU PROLINE EN POSITION 2 ; II) UN TAUX DE SIMILITUDE RELATIVEMENT ELEVE ENTRE LES SEQUENCES DE LEURS PRECURSEURS ; III) UNE EXPRESSION DE LEUR GENES PRESQUE EXCLUSIVEMENT LIMITEE AU SYSTEME NERVEUX CENTRAL, CONTRAIREMENT AUX GENES DE TYPE SS1 QUI SONT EGALEMENT EXPRIMES DANS LE PANCREAS ET LE TRACTUS GASTRO-INTESTINAL. L'EXISTENCE D'UN GENE SS2 A LA FOIS CHEZ LES AMPHIBIENS ET CHEZ LES DIPNEUSTES MONTRE QUE LA DUPLICATION DONT CE GENE EST ISSU EST ANTERIEURE A L'EMERGENCE DES TETRAPODES. DE TELLES CONCLUSIONS SONT CONFORTEES PAR LA PRESENCE, RECEMMENT ETABLIE, D'UNE PSS2 CHEZ LES TELEOSTEENS. PAR AILLEURS, LA DECOUVERTE CHEZ LES MAMMIFERES DE LA CORTISTATINE, UN NOUVEAU PEPTIDE VISIBLEMENT APPARENTE A LA SS2, MONTRE QUE LE GENE DE LA PSS2 EXISTE PROBABLEMENT CHEZ TOUS LES OSTEICHTHYENS.ROUEN-BU Sciences (764512102) / SudocSudocFranceF